Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 781–795 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-6230 USF1 Gene Hyperlipidemia, Familial Combined Susceptibility Test This test evaluates the USF1 gene for pathogenic variants linked to familial combined hyperlipidemia.	Whole Blood (Peripheral)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["USF1 gene pathogenic variants", "Inherited risk for hyperlipidemia"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusion (wait 4 weeks)"] Indications ["Family history of premature cardiovascular disease", "Elevated cholesterol and triglycerides", "Screening for inherited hyperlipidemia risk"] Measurement technique Confirm with laboratory Codes LOINC: 92606-2 ICD-10: E78.49 Clinical summary This test evaluates the USF1 gene for pathogenic variants linked to familial combined hyperlipidemia.
TEST-2747 Usher Syndrome NGS & Sanger Testing Test This diagnostic test evaluates for pathogenic variants in genes associated with Usher syndrome, a genetic disorder causing progressive vision loss and hearing impairment.	Whole blood	45 working days	3,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in Usher syndrome genes", "Genetic mutations causing dual sensory loss"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Suspected Usher syndrome", "Progressive hearing loss and vision loss", "Family history of Usher syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q87.8 Clinical summary This diagnostic test evaluates for pathogenic variants in genes associated with Usher syndrome, a genetic disorder causing progressive vision loss and hearing impairment.
TEST-5394 VIPAS39 Gene NGS Test This test identifies pathogenic variants in the VIPAS39 gene associated with Arthrogryposis, Renal dysfunction, and Cholestasis (ARC) syndrome type 2.	Peripheral whole blood or buccal swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the VIPAS39 gene", "Copy number variants in the VIPAS39 gene"] Parameters [] Preparation ["No fasting required", "No medication changes required"] Indications ["Clinical suspicion of ARC syndrome type 2", "Infants presenting with arthrogryposis, renal dysfunction, and cholestasis"] Measurement technique Confirm with laboratory Codes LOINC: 81260-5 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants in the VIPAS39 gene associated with Arthrogryposis, Renal dysfunction, and Cholestasis (ARC) syndrome type 2.
TEST-3114 Von Willebrand Factor (VWF) Gene Genetic Test This test identifies pathogenic variants in the VWF gene associated with von Willebrand disease.	Peripheral whole blood (EDTA) or FTA card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the VWF gene", "Small nucleotide variants, insertions, deletions"] Parameters [] Preparation ["No fasting required", "Inform genetic counselor about all current medications"] Indications ["Individuals with unexplained bleeding", "Heavy menstrual bleeding", "Family history of VWD", "Pre-surgical evaluation with inconclusive standard coagulation tests"] Measurement technique Confirm with laboratory Codes LOINC: 82652-2 ICD-10: D68.0 Clinical summary This test identifies pathogenic variants in the VWF gene associated with von Willebrand disease.
TEST-4135 VPS13B Gene Cohen Syndrome Genetic Test This test identifies pathogenic variants in the VPS13B gene, confirming a diagnosis of Cohen syndrome.	Whole blood (EDTA), FTA card, or extracted DNA	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the VPS13B gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)"] Parameters [] Preparation ["No fasting required", "Genetic counseling session is mandatory prior to sample collection"] Indications ["Clinical suspicion of Cohen syndrome", "Family history of Cohen syndrome", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 83112-3 ICD-10: Q87.89 Clinical summary This test identifies pathogenic variants in the VPS13B gene, confirming a diagnosis of Cohen syndrome.
TEST-5678 VPS37A Gene SPG53 Genetic Test This test identifies pathogenic variants in the VPS37A gene, confirming a diagnosis of hereditary spastic paraplegia type 53 (SPG53).	Peripheral whole blood (EDTA) or FTA card finger-prick	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VPS37A gene pathogenic variants", "Copy Number Variants (CNVs) in VPS37A"] Parameters [] Preparation [] Indications ["Suspected hereditary spastic paraplegia type 53 (SPG53)", "Family risk assessment for SPG53", "Guiding targeted management"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G11.4, G11.9 Clinical summary This test identifies pathogenic variants in the VPS37A gene, confirming a diagnosis of hereditary spastic paraplegia type 53 (SPG53).
TEST-3226 VPS45 Gene Severe Congenital Neutropenia Type 5 Genetic Test This test identifies pathogenic variants in the VPS45 gene associated with severe congenital neutropenia type 5.	Peripheral whole blood (EDTA), 3–5 mL; alternative: buccal swab or extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["VPS45 gene sequence", "Pathogenic variants"] Parameters [] Preparation ["Mandatory genetic counseling session prior to sample collection", "Disclose all immunosuppressive medications", "Disclose recent G-CSF use", "Disclose history of stem cell transplantation"] Indications ["Autosomal recessive severe congenital neutropenia type 5 (SCN5) caused by biallelic VPS45 mutations", "Persistent neutropenia of unknown cause", "Family history of severe congenital neutropenia"] Measurement technique Confirm with laboratory Codes LOINC: 81369-6 ICD-10: D70.0 Clinical summary This test identifies pathogenic variants in the VPS45 gene associated with severe congenital neutropenia type 5.
TEST-2382 WASHC5 Gene Ritscher‑Schinzel Syndrome Type 1 Genetic Test This genetic test identifies pathogenic mutations in the WASHC5 gene, confirming Ritscher‑Schinzel syndrome type 1.	Peripheral whole blood	3–4 Weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the WASHC5 gene"] Parameters [] Preparation [] Indications ["Infants and children with clinical features suggestive of Ritscher‑Schinzel syndrome", "Family members of an index case for recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 94473-0 ICD-10: Q87.89 Clinical summary This genetic test identifies pathogenic mutations in the WASHC5 gene, confirming Ritscher‑Schinzel syndrome type 1.
TEST-2925 WDR19 Gene Cranioectodermal Dysplasia Type 4 Genetic Test This test detects pathogenic variants, including single nucleotide variants, indels, and copy number variants, within the WDR19 gene associated with cranioectodermal dysplasia type...	Whole Blood (3 mL EDTA), Extracted DNA, or One Drop Blood on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single Nucleotide Variants (SNVs) in WDR19 gene", "Insertions/Deletions (Indels) in WDR19 gene", "Copy Number Variants (CNVs) in WDR19 gene"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Clinical suspicion of cranioectodermal dysplasia type 4 (CED4)", "Family history of CED4", "Need for genetic confirmation for management and counselling"] Measurement technique Confirm with laboratory Codes LOINC: 98747-9 ICD-10: Q87.8 Clinical summary This test detects pathogenic variants, including single nucleotide variants, indels, and copy number variants, within the WDR19 gene associated with cranioectodermal dysplasia type 4.
TEST-1313 Whole Genome Genetic Mapping Test This test evaluates the entire genome for single nucleotide polymorphisms (SNPs) and copy number variations (CNVs) to assess genetic predispositions.	Peripheral Whole Blood	8 weeks from sample collection	30,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single Nucleotide Polymorphisms (SNPs)", "Copy Number Variations (CNVs)", "Pharmacogenomic profiles", "Ancestry markers"] Parameters [] Preparation ["No fasting required", "No special preparation required"] Indications ["Proactive health screening", "Pharmacogenomic profiling", "Ancestry analysis", "Carrier screening", "Pediatric developmental concerns"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Z13.89 Clinical summary This test evaluates the entire genome for single nucleotide polymorphisms (SNPs) and copy number variations (CNVs) to assess genetic predispositions.
TEST-3448 Wilson Disease ATP7B Gene Mutation Detection Test This test identifies pathogenic variants in the ATP7B gene to confirm a diagnosis of Wilson disease.	Whole Blood	Up to 2 months from sample receipt	6,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP7B gene mutations", "Pathogenic variants"] Parameters [] Preparation ["No special fasting required", "No medication changes required"] Indications ["Symptomatic patients with suspected Wilson disease", "Presymptomatic screening of at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 21636-0 ICD-10: E83.01 Clinical summary This test identifies pathogenic variants in the ATP7B gene to confirm a diagnosis of Wilson disease.
TEST-4723 WNT1 Gene Osteogenesis Imperfecta Type XV Genetic Test This test identifies pathogenic variants in the WNT1 gene associated with Osteogenesis Imperfecta Type XV.	Whole Blood (EDTA) or Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["WNT1 gene pathogenic variants"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusions or stem cell transplants"] Indications ["Suspected Osteogenesis Imperfecta Type XV", "Family history of Osteogenesis Imperfecta"] Measurement technique Confirm with laboratory Codes LOINC: 81723-5 ICD-10: Q78.0 Clinical summary This test identifies pathogenic variants in the WNT1 gene associated with Osteogenesis Imperfecta Type XV.
TEST-2224 WNT7A Gene Sequencing (NGS) Test This test evaluates the WNT7A gene for variants associated with Schinzel phocomelia syndrome.	Peripheral whole blood (EDTA) or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["WNT7A gene sequence", "Copy Number Variations (CNVs) in WNT7A"] Parameters [] Preparation [] Indications ["Suspected Schinzel phocomelia syndrome", "Family history of limb deficiency disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81231-0 ICD-10: Q87.8 Clinical summary This test evaluates the WNT7A gene for variants associated with Schinzel phocomelia syndrome.
TEST-1052 WS1 Full Gene Sequence Analysis (Wolfram Syndrome, DIDMOAD) Test This test evaluates the WFS1 gene for pathogenic variants associated with Wolfram syndrome (DIDMOAD). It identifies genetic mutations that cause this rare disorder.	Peripheral blood, amniotic fluid, chorionic villi, cord blood	4–6 weeks	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["WFS1 gene sequence", "Pathogenic variants (SNVs, small indels)"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Suspected Wolfram syndrome based on clinical presentation", "Family history of Wolfram syndrome", "Confirmation of diagnosis at a molecular level"] Measurement technique Confirm with laboratory Codes LOINC: 95419-5 ICD-10: Q87.8, Z15.0, Z13.7 Clinical summary This test evaluates the WFS1 gene for pathogenic variants associated with Wolfram syndrome (DIDMOAD). It identifies genetic mutations that cause this rare disorder.
TEST-4486 XPA Gene Xeroderma Pigmentosum Group A (XPA) Genetic Test This test identifies germline mutations in the XPA gene associated with Xeroderma Pigmentosum Group A.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["XPA gene mutations", "SNVs", "Indels", "CNVs"] Parameters [] Preparation ["No fasting required", "No medication adjustments required", "Genetic counseling and pedigree chart review mandatory"] Indications ["Siblings of confirmed Xeroderma Pigmentosum patients", "Individuals with unexplained severe photosensitivity", "Family history of Xeroderma Pigmentosum"] Measurement technique Confirm with laboratory Codes LOINC: 8827-2 ICD-10: Q82.1 Clinical summary This test identifies germline mutations in the XPA gene associated with Xeroderma Pigmentosum Group A.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.